As a sector closely pertinent to people’s livelihood, the life science sector has always been, and will continue to be, a focus of China’s antitrust enforcement. In 2018, China’s public antitrust enforcement entered into a transitional period due to the internal institutional reform, which will remodel China’s antitrust enforcement regime with a series of significant changes to take place. This article highlights the major changes brought by the institutional r
...THIS ARTICLE IS NOT AVAILABLE FOR IP ADDRESS 18.97.14.82
Please verify email or join us to access premium content!